Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.

Stage-Gate innovation funnel human risk assessment tools nanomaterials new approach methodologies safer by design

Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
02 2020
Historique:
received: 23 08 2019
revised: 09 12 2019
pubmed: 9 1 2020
medline: 8 5 2021
entrez: 9 1 2020
Statut: ppublish

Résumé

Advanced material development, including at the nanoscale, comprises costly and complex challenges coupled to ensuring human and environmental safety. Governmental agencies regulating safety have announced interest toward acceptance of safety data generated under the collective term New Approach Methodologies (NAMs), as such technologies/approaches offer marked potential to progress the integration of safety testing measures during innovation from idea to product launch of nanomaterials. Divided in overall eight main categories, searchable databases for grouping and read across purposes, exposure assessment and modeling, in silico modeling of physicochemical structure and hazard data, in vitro high-throughput and high-content screening assays, dose-response assessments and modeling, analyses of biological processes and toxicity pathways, kinetics and dose extrapolation, consideration of relevant exposure levels and biomarker endpoints typify such useful NAMs. Their application generally agrees with articulated stakeholder needs for improvement of safety testing procedures. They further fit for inclusion and add value in nanomaterials risk assessment tools. Overall 37 of 50 evaluated NAMs and tiered workflows applying NAMs are recommended for considering safer-by-design innovation, including guidance to the selection of specific NAMs in the eight categories. An innovation funnel enriched with safety methods is ultimately proposed under the central aim of promoting rigorous nanomaterials innovation.

Identifiants

pubmed: 31913582
doi: 10.1002/smll.201904749
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1904749

Informations de copyright

© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

a) A. G. Oomen, K. G. Steinhäuser, E. A. J. Bleeker,F. van Broekhuizen, A. Sips, S. Dekkers, S. W. P. Wijnhoven, P. G. Sayre, NanoImpact 2018, 9, 1;
b) Y. Zhao, A. Nel, K. Riehemann, Small 2013, 9, 1426.
a) M. H. Kathawala, S. Xiong, M. Richards, K. W. Ng, S. George, S. C. J. Loo, Small 2013, 9, 1504;
b) T. Xia, D. Malasarn, S. Lin, Z. Ji, H. Zhang, R. J. Miller, A. A. Keller, R. M. Nisbet, B. H. Harthorn, H. A. Godwin, H. S. Lenihan, R. Liu, J. Gardea-Torresdey, Y. Cohen, L. Mädler, P. A. Holden, J. I. Zink, A. E. Nel, Small 2013, 9, 1428;
c) R. Franken, E. Kuijpers, E. Zondervan, A. Sánchez Jiménez, I. Basinas, W. Fransman, unpublished.
a) A. Maertens, N. Anastas, P. Spencer, M. Stephens, A. Goldberg, T. Hartung, ALTEX 2014, 31, 243;
b) S. Lin, T. Yu, Z. Yu, X. Hu, D. Yin, Adv. Mater. 2018, 30, 1705691.
a) A. Kraegeloh, B. Suarez-Merino, T. Sluijters, C. Micheletti, Nanomaterials 2018, 8, 239;
b) L. Soeteman-Hernandez, M. Apostolova, C. Bekker, H. Braakhuis, S. Dekkers, R. Grafström, M. Groenewold, Y. Handzhiyski, P. Herbeck-Engel, K. Hoehener, V. Karagkiozaki, S. Kelly, A. Kraegeloh, S. Logothetidis, C. Micheletti, P. Nymark, A. Oomen, T. Oosterwijk, I. Rodríguez-LLopis, A. Sanchez Jiménez, A. Sips, B. Suarez-Merino, I. Tavernaro, J. van Engelen, S. Wijnhoven, C. Noorlander, Mater. Today Commun. 2019, 20, 100548.
a) Y. Adeleye, M. Andersen, R. Clewell, M. Davies, M. Dent, S. Edwards, P. Fowler, S. Malcomber, B. Nicol, A. Scott, S. Scott, B. Sun, C. Westmoreland, A. White, Q. Zhang, P. L. Carmichael, Toxicology 2015, 332, 102;
b) T. Malloy, V. Zaunbrecher, E. Beryt, R. Judson, R. Tice, P. Allard, A. Blake, I. Cote, H. Godwin, L. Heine, P. Kerzic, J. Kostal, G. Marchant, J. McPartland, K. Moran, A. Nel, O. Ogunseitan, M. Rossi, K. Thayer, J. Tickner, M. Whittaker, K. Zarker, Integr. Environ. Assess. Manage. 2017, 13, 915;
c) R. Grafström, P. Nymark, V. Hongisto, O. Spjuth, R. Ceder, E. Willighagen, B. Hardy, S. Kaski, P. Kohonen, Altern. Lab. Anim. 2015, 43, 325;
d) A. Nel, T. Xia, H. Meng, X. Wang, S. Lin, Z. Ji, H. Zhang, Acc. Chem. Res. 2013, 46, 607;
e) R. Damoiseaux, S. George, M. Li, S. Pokhrel, Z. Ji, B. France, T. Xia, E. Suarez, R. Rallo, L. Mädler, Y. Cohen, E. M. V. Hoek, A. Nel, Nanoscale 2011, 3, 1345;
f) H. Godwin, C. Nameth, D. Avery, L. L. Bergeson, D. Bernard, E. Beryt, W. Boyes, S. Brown, A. J. Clippinger, Y. Cohen, M. Doa, C. O. Hendren, P. Holden, K. Houck, A. B. Kane, F. Klaessig, T. Kodas, R. Landsiedel, I. Lynch, T. Malloy, M. B. Miller, J. Muller, G. Oberdorster, E. J. Petersen, R. C. Pleus, P. Sayre, V. Stone, K. M. Sullivan, J. Tentschert, P. Wallis, A. E. Nel, ACS Nano 2015, 9, 3409;
g) V. Stone, H. J. Johnston, D. Balharry, J. M. Gernand, M. Gulumian, Risk Anal. 2016, 36, 1538;
h) N. Burden, K. Aschberger, Q. Chaudhry, M. J. D. Clift, P. Fowler, H. Johnston, R. Landsiedel, J. Rowland, V. Stone, S. H. Doak, Regul. Toxicol. Pharmacol. 2017, 91, 257;
i) I. Rusyn, N. Greene, Toxicol. Sci. 2018, 161, 276;
j) T. Luechtefeld, C. Rowlands, T. Hartung, Toxicol. Res. 2018, 7, 732.
ECHA, New Approach Methodologies in Regulatory Science: Proceedings of a scientific workshop, https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&ved=2ahUKEwjR3ruGnanfAhWJECwKHZTBC3YQFjABegQICBAC&url=https%3A%2F%2Fecha.europa.eu%2Fdocuments%2F10162%2F22816069%2Fscientific_ws_proceedings_en.pdf&usg=AOvVaw2GdWJG8UvpIy6W5svhQp6F (accessed: October 2016).
a) L. Yan, F. Zhao, J. Wang, Y. Zu, Z. Gu, Y. Zhao, Adv. Mater. 2019, 31, 1805391;
b) S. M. Hussain, L. K. Braydich-Stolle, A. M. Schrand, R. C. Murdock, K. O. Yu, D. M. Mattie, J. J. Schlager, M. Terrones, Adv. Mater. 2009, 21, 1549.
R. G. Cooper, Bus. Horiz. 1990, 33, 44.
R. G. Cooper, Res.-Technol. Manage. 2014, 57, 20.
a) B. Liguori, S. F. Hansen, A. Baun, K. A. Jensen, NanoImpact 2016, 2, 1;
b) D. Hristozov, S. Gottardo, E. Semenzin, A. Oomen, P. Bos, W. Peijnenburg, M. van Tongeren, B. Nowack, N. Hunt, A. Brunelli, J. J. Scott-Fordsmand, L. Tran, A. Marcomini, Environ. Int. 2016, 95, 36.
R. Franken, M. Heringa, T. Oosterwijk, S. Nørgaard Sørensen, M. Dal Maso, W. Fransman, T. Kanerva, B. Liguori, M. Poikkimäki, I. Rodriguez, A. Säämänen, H. Stockmann-Juvala, B. Suarez, K. Jensen, R. Stierum, NanoImpact 2020, 17, 100191.
a) caLIBRAte, www.nanocalibrate.eu (accessed: June 2019);
b) eNanoMapper, http://www.enanomapper.net/ (accessed: June 2019);
c) GUIDEnano, http://www.guidenano.eu/ (accessed: June 2019);
d) NANOSOLUTIONS, https://nanosolutionsfp7.com/ (accessed: June 2019);
e) SUN, http://www.sun-fp7.eu/ (accessed: June 2019);
f) NANoREG, http://www.nanoreg.eu/ (accessed: June 2019);
g) NanoReg2, http://www.nanoreg2.eu/ (accessed: June 2019);
h) SmartNanoTox, http://www.smartnanotox.eu/ (accessed: June 2019);
i) PATROLS, https://www.patrols-h2020.eu/ (accessed: June 2019);
j) GRACIOUS, https://www.h2020gracious.eu/ (accessed: June 2019);
k) NanoSolveIT, http://nanosolveit.eu/ (accessed: June 2019);
l) Gov4Nano, https://www.gov4nano.eu/ (accessed: June 2019).
A. Haase, F. Klaessig, N. C. Members, Nanoinformatics Roadmap 2030, https://www.nanosafetycluster.eu/Nanoinformatics2030.html (accessed: November 2018).
A. Worth, K. Aschberger, D. Asturiol Bofill, J. Bessems, K. Gerloff, R. Graepel, E. Joossens, L. Lamon, T. Palosaari, A. Richarz, Computational Models for the Safety Assessment of Nanomaterials, Publications Office of the European Union, Luxembourg 2017, https://data.jrc.ec.europa.eu/dataset/jrc-eurl-ecvam-nanocomput.
ProSafe, The ProSafe White Paper: Towards a more effective and efficient governance and regulation of nanomaterials, https://www.rivm.nl/en/About_RIVM/Mission_and_strategy/International_Affairs/International_Projects/Completed/ProSafe/ProSafe_Deliverables/ProSafe_White_Paper_updated_version_20170922 (accessed: 2017).
a) D. Brouwer, R. Boessen, B. van Duuren-Stuurman, D. Bard, C. Moehlmann, C. Bekker, W. Fransman, R. Klein Entink, Ann. Occup. Hyg. 2016, 60, 949;
b) P. Nymark, P. Kohonen, V. Hongisto, R. Grafström, Ann. Am. Thorac. Soc. 2018, 15, S91;
c) S. Halappanavar, U. Vogel, H. Wallin, C. L. Yauk, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2018, 10, e1465;
d) A. J. Koivisto, K. I. Kling, O. Hänninen, M. Jayjock, J. Löndahl, A. Wierzbicka, A. S. Fonseca, K. Uhrbrand, B. E. Boor, A. S. Jiménez, K. Hämeri, M. D. Maso, S. F. Arnold, K. A. Jensen, M. Viana, L. Morawska, T. Hussein, Sci. Total Environ. 2019, 668, 13.
T. van Harmelen, E. K. Zondervan-van den Beuken, D. H. Brouwer, E. Kuijpers, W. Fransman, H. B. Buist, T. N. Ligthart, I. Hincapié, R. Hischier, I. Linkov, B. Nowack, J. Studer, L. Hilty, C. Som, Environ. Int. 2016, 91, 150.
B. Van Duuren-Stuurman, S. R. Vink, K. J. M. Verbist, H. G. A. Heussen, D. H. Brouwer, D. E. D. Kroese, M. F. J. Van Niftrik, E. Tielemans, W. Fransman, Ann. Work Exposures Health 2012, 56, 525.
GUIDEnano-D9.3, GUIDEnano Tool v3 online, 2017.
a) caLIBRAte-D2.2, Review of current hazard, exposure and (integrated) HRA models considering their input requirements and applicability at the Cooper innovation stage-gates defined, 2017;
b) caLIBRAte-D2.3, Guidance for implementation of a set of existing HRA models at appropriate stages in the production processes, 2018.
T. Hartung, S. Bremer, S. Casati, S. Coecke, R. Corvi, S. Fortaner, L. Gribaldo, M. Halder, S. Hoffmann, A. Roi, P. Prieto, E. Sabbioni, L. Scott, A. Worth, V. Zuang, Altern. Lab. Anim. 2004, 32, 467.
a) R. Judson, R. Kavlock, M. Martin, D. Reif, K. Houck, T. Knudsen, A. Richard, R. R. Tice, M. Whelan, M. Xia, R. Huang, C. Austin, G. Daston, T. Hartung, J. R. Fowle 3rd, W. Wooge, W. Tong, D. Dix, ALTEX 2013, 30, 51;
b) T. Hartung, T. Luechtefeld, A. Maertens, A. Kleensang, ALTEX 2013, 30, 3.
a) NanoReg2-D3.2, Database/structural model and report describing the relationships between functionality, physiochemical properties and hazard, and allowing for integration in the safe innovation approach, 2018;
b) caLIBRAte-D2.4, Review article with completed evaluation and guidance on prioritization of innovative hazard exposure and risk assessment models towards applications in the stage-gate model, 2018;
c) caLIBRAte-D2.5, Integrated HRA tools, in the format of a suite of models and written guidance documentation, 2019.
a) N. Jeliazkova, C. Chomenidis, P. Doganis, B. Fadeel, R. Grafström, B. Hardy, J. Hastings, M. Hegi, V. Jeliazkov, N. Kochev, P. Kohonen, C. R. Munteanu, H. Sarimveis, B. Smeets, P. Sopasakis, G. Tsiliki, D. Vorgrimmler, E. Willighagen, Beilstein J. Nanotechnol. 2015, 6, 1609;
b) J. Hastings, N. Jeliazkova, G. Owen, G. Tsiliki, C. R. Munteanu, C. Steinbeck, E. Willighagen, J. Biomed. Semantics 2015, 6, 10;
c) C. Chomenidis, G. Drakakis, G. Tsiliki, E. Anagnostopoulou, A. Valsamis, P. Doganis, P. Sopasakis, H. Sarimveis, J. Chem. Inf. Model. 2017, 57, 2161;
d) C. Hendren, C. Powers, M. Hoover, S. Harper, Beilstein J. Nanotechnol. 2015, 6, 1752;
e) M. L. Fernández-Cruz, D. Hernández-Moreno, J. Catalán, R. K. Cross, H. Stockmann-Juvala, J. Cabellos, V. R. Lopes, M. Matzke, N. Ferraz, J. J. Izquierdo, J. M. Navas, M. Park, C. Svendsen, G. Janer, Environ. Sci.: Nano 2018, 5, 381;
f) caLIBRAte-D5.3, Document on quality criteria for data, 2017;
g) A. Mech, K. Rasmussen, P. Jantunen, L. Aicher, M. Alessandrelli, U. Bernauer, E. A. J. Bleeker, J. Bouillard, P. Di Prospero Fanghella, R. Draisci, M. Dusinska, G. Encheva, G. Flament, A. Haase, Y. Handzhiyski, F. Herzberg, J. Huwyler, N. R. Jacobsen, V. Jeliazkov, N. Jeliazkova, P. Nymark, R. Grafström, A. G. Oomen, M. L. Polci, C. Riebeling, J. Sandström, B. Shivachev, S. Stateva, S. Tanasescu, R. Tsekovska, H. Wallin, M. F. Wilks, S. Zellmer, M. D. Apostolova, Nanotoxicology 2018, 13, 119;
h) NanoReg2-D1.7, Report on validated grouping approach, 2018;
i) M. V. D. Z. Park, J. Catalán, N. Ferraz, J. Cabellos, R. Vanhauten, S. Vázquez-Campos, G. Janer, Nanotoxicology 2018, 12, 652;
j) PEROSH, http://www.perosh.eu/research-projects/perosh-projects/necid/ (accessed: June 2019);
k) GESTIS, http://limitvalue.ifa.dguv.de (accessed: June 2019);
l) L. D. Burgoon, Appl. In Vitro Toxicol. 2017, 3, 278.
a) GUIDEnano D4.3, Updated exposure module to be incorporated in the GUIDEnano Tool v3, available upon request;
b) H. Marquart, T. Schneider, H. Goede, M. Tischer, J. Schinkel, N. Warren, W. Fransman, S. Spaan, M. Van Tongeren, H. Kromhout, E. Tielemans, J. W. Cherrie, Ann. Occup. Hyg. 2011, 55, 989;
c) P. J. Drivas, P. A. Valberg, B. L. Murphy, R. Wilson, Indoor Air 1996, 6, 271;
d) H. Korhonen, K. E. J. Lehtinen, M. Kulmala, Atmos. Chem. Phys. 2004, 4, 757;
e) A. J. Koivisto, A. C. Ø. Jensen, M. Levin, K. I. Kling, M. D. Maso, S. H. Nielsen, K. A. Jensen, I. K. Koponen, Environ. Sci.: Processes Impacts 2015, 17, 62;
f) A. C. Ø. Jensen, M. Dal Maso, A. J. Koivisto, E. Belut, A. Meyer-Plath, M. Van Tongeren, A. S. Jimenez, I. Tuinman, M. Domat, J. Toftum, I. K. Koponen, Environments52, 2018, 5;
g) M. T. D. Cronin, J. C. Madden, in In Silico Toxicology-An Introduction, in In Silico Toxicology: Principles and Applications, The Royal Society of Chemistry 2010, pp. 1-10;
h) J. Delmaar, A. Schuur, ConsExpo Web: consumer exposure models. Model documentation, https://www.rivm.nl/bibliotheek/rapporten/2017-0197.html, (accessed: June 2019);
i) J. van Hemmen, J. Auffarth, P. Evans, B. Rajan-Sithamparanadarajah, H. Marquart, R. Oppl, Ann. Occup. Hyg. 2003, 47, 595.
a) A. Cherkasov, E. N. Muratov, D. Fourches, A. Varnek, I. I. Baskin, M. Cronin, J. Dearden, P. Gramatica, Y. C. Martin, R. Todeschini, V. Consonni, V. E. Kuz'min, R. Cramer, R. Benigni, C. Yang, J. Rathman, L. Terfloth, J. Gasteiger, A. Richard, A. Tropsha, J. Med. Chem. 2014, 57, 4977;
b) OECD, ECHA, http://www.qsartoolbox.org (accessed: June 2019).
a) A. Toropova, A. Toropov, J. Theor. Biol. 2017, 416, 113;
b) T. Puzyn, N. Jeliazkova, H. Sarimveis, R. L. Marchese Robinson, V. Lobaskin, R. Rallo, A.-N. Richarz, A. Gajewicz, M. G. Papadopulos, J. Hastings, M. T. D. Cronin, E. Benfenati, A. Fernández, Food Chem. Toxicol. 2018, 112, 478;
c) J. T. K. Quik, M. Bakker, D. van de Meent, M. Poikkimäki, M. Dal Maso, W. Peijnenburg, NanoImpact 2018, 11, 58;
d) A. Gajewicz, Nanoscale 2017, 9, 8435;
e) A. Gajewicz, T. Puzyn, K. Odziomek, P. Urbaszek, A. Haase, C. Riebeling, A. Luch, M. A. Irfan, R. Landsiedel, M. van der Zande, H. Bouwmeester, Nanotoxicology 2018, 12, 1;
f) G. Tsiliki, C. R. Munteanu, J. A. Seoane, C. Fernandez-Lozano, H. Sarimveis, E. L. Willighagen, J. Cheminf. 2015, 7, 46;
g) G. Tsiliki, P. Nymark, P. Kohonen, R. Grafström, H. Sarimveis, Small Methods 2017, 1, 1700139;
h) N. Shandilya, E. Kuijpers, I. Tuinman, W. Fransman, unpublished;
i) Y. Low, A. Sedykh, D. Fourches, A. Golbraikh, M. Whelan, I. Rusyn, A. Tropsha, Chem. Res. Toxicol. 2013, 26, 1199;
j) C. D. Walkey, J. B. Olsen, F. Song, R. Liu, H. Guo, D. W. H. Olsen, Y. Cohen, A. Emili, W. C. W. Chan, ACS Nano 2014, 8, 2439.
G. Kaptay, Int. J. Pharm. 2012, 430, 253.
a) P. Kohonen, J. Parkkinen, E. Willighagen, R. Ceder, K. Wennerberg, S. Kaski, R. Grafström, Nat. Commun. 2017, 8, 15932;
b) J. Lamb, E. D. Crawford, D. Peck, J. W. Modell, I. C. Blat, M. J. Wrobel, J. Lerner, J.-P. Brunet, A. Subramanian, K. N. Ross, M. Reich, H. Hieronymus, G. Wei, S. A. Armstrong, S. J. Haggarty, P. A. Clemons, R. Wei, S. A. Carr, E. S. Lander, T. R. Golub, Science 2006, 313, 1929.
K. Gerloff, B. Landesmann, A. Worth, S. Munn, T. Palosaari, M. Whelan, Comput. Toxicol. 2017, 1, 3.
R. R. Tice, C. P. Austin, R. J. Kavlock, J. R. Bucher, Environ. Health Perspect. 2013, 121, 756.
a) R. P. Valle, T. Wu, Y. Y. Zuo, ACS Nano 2015, 9, 5413;
b) J. Sørli, Y. Huang, E. Da Silva, J. Hansen, Y. Zuo, M. Frederiksen, A. Nørgaard, N. Ebbehøj, S. Larsen, K. Hougaard, ALTEX 2018, 35, 26;
c) J. B. Sørli, E. Da Silva, P. Bäckman, M. Levin, B. L. Thomsen, I. K. Koponen, S. T. Larsen, Am. J. Respir. Cell Mol. Biol. 2016, 54, 306;
d) Y. Chen, Y. Yang, B. Xu, S. Wang, B. Li, J. Ma, J. Gao, Y. Y. Zuo, S. Liu, J. Environ. Sci. 2017, 62, 100;
e) J. Catalán, H. Stockmann-Juvala, H. Norppa, Nanotoxicology 2017, 11, 964;
f) B. C. Nelson, C. W. Wright, Y. Ibuki, M. Moreno-Villanueva, H. L. Karlsson, G. Hendriks, C. M. Sims, N. Singh, S. H. Doak, Mutagenesis 2017, 32, 215;
g) A. R. Collins, B. Annangi, L. Rubio, R. Marcos, M. Dorn, C. Merker, I. Estrela-Lopis, M. R. Cimpan, M. Ibrahim, E. Cimpan, M. Ostermann, A. Sauter, N. E. Yamani, S. Shaposhnikov, S. Chevillard, V. Paget, R. Grall, J. Delic, F. G. de-Cerio, B. Suarez-Merino, V. Fessard, K. N. Hogeveen, L. M. Fjellsbø, E. R. Pran, T. Brzicova, J. Topinka, M. J. Silva, P. E. Leite, A. R. Ribeiro, J. M. Granjeiro, R. Grafström, A. Prina-Mello, M. Dusinska, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2017, 9, e1413;
h) H. Meng, T. Xia, S. George, A. E. Nel, ACS Nano 2009, 3, 1620;
i) M. A. Vetten, N. Tlotleng, D. Tanner Rascher, A. Skepu, F. K. Keter, K. Boodhia, L.-A. Koekemoer, C. Andraos, R. Tshikhudo, M. Gulumian, Part. Fibre Toxicol. 2013, 10, 50;
j) J. M. George, M. Magogotya, M. A. Vetten, A. V. Buys, M. Gulumian, Toxicol. Sci. 2017, 156, 149;
k) I. Hansjosten, J. Rapp, L. Reiner, R. Vatter, S. Fritsch-Decker, R. Peravali, T. Palosaari, E. Joossens, K. Gerloff, P. Macko, M. Whelan, D. Gilliland, I. Ojea-Jimenez, M. Monopoli, L. Rocks, D. Garry, K. Dawson, P. Röttgermann, A. Murschhauser, J. Rädler, S. Tang, P. Gooden, M. Belinga-Desaunay, A. Khan, S. Briffa, E. Guggenheim, A. Papadiamantis, I. Lynch, E. Valsami-Jones, S. Diabaté, C. Weiss, Arch. Toxicol. 2018, 92, 633;
l) V. Hongisto, P. Nymark, J. Hattara, P. Kohonen, R. Grafström, in New Tools and Approaches for Nanomaterial Safety Assessment, Malaga, 2017, https://www.researchgate.net/publication/315614185_Abstracts_from_New_Tools_and_Approaches_for_Nanomaterial_Safety_Assessment_conference_7-9_February_2017_Malaga_Spain.
G. T. Ankley, S. W. Edwards, Curr. Opin. Toxicol. 2018, 9, 1.
L. T. Haber, M. L. Dourson, B. C. Allen, R. C. Hertzberg, A. Parker, M. J. Vincent, A. Maier, A. R. Boobis, Crit. Rev. Toxicol. 2018, 48, 387.
K. Shao, J. S. Gift, R. W. Setzer, Toxicol. Appl. Pharmacol. 2013, 272, 767.
W. Slob, R. W. Setzer, Crit. Rev. Toxicol. 2014, 44, 270.
a) NIOSH, Occupational exposure to carbon nanotubes and nanofibers, https://www.cdc.gov/niosh/docs/2013-145/default.html (accessed: June 2019);
b) H. M. Braakhuis, S. K. Kloet, S. Kezic, F. Kuper, M. V. D. Z. Park, S. Bellmann, M. van der Zande, S. Le Gac, P. Krystek, R. J. B. Peters, I. M. C. M. Rietjens, H. Bouwmeester, Arch. Toxicol. 2015, 89, 1469;
c) I. Gosens, F. R. Cassee, M. Zanella, L. Manodori, A. Brunelli, A. L. Costa, B. G. H. Bokkers, W. H. de Jong, D. Brown, D. Hristozov, V. Stone, Nanotoxicology 2016, 10, 1084;
d) I. Gosens, A. Kermanizadeh, N. R. Jacobsen, A.-G. Lenz, B. Bokkers, W. H. de Jong, P. Krystek, L. Tran, V. Stone, H. Wallin, T. Stoeger, F. R. Cassee, PLoS One 2015, 10, e0126934.
V. Subramanian, E. Semenzin, D. Hristozov, A. Zabeo, I. Malsch, E. McAlea, F. Murphy, M. Mullins, T. van Harmelen, T. Ligthart, I. Linkov, A. Marcomini, J. Nanopart. Res. 2016, 18, 89.
a) L. Yang, B. C. Allen, R. S. Thomas, BMC Genomics 2007, 8, 387;
b) S. Labib, A. Williams, C. L. Yauk, J. K. Nikota, H. Wallin, U. Vogel, S. Halappanavar, Part. Fibre Toxicol. 2015, 13, 15;
c) S. Halappanavar, L. Rahman, J. Nikota, S. Poulsen, Y. Ding, P. Jackson, H. Wallin, O. Schmid, U. Vogel, A. Williams, NanoImpact 2019, 14, 100158.
a) J. L. Dean, Q. J. Zhao, J. C. Lambert, B. S. Hawkins, R. S. Thomas, S. C. Wesselkamper, Toxicol. Sci. 2017, 157, 85;
b) D. G. DeBord, L. Burgoon, S. W. Edwards, L. T. Haber, M. H. Kanitz, E. Kuempel, R. S. Thomas, B. Yucesoy, J. Occup. Environ. Hyg. 2015, 12, S41;
c) P. Kohonen, P. Nymark, R. Grafström, in 10th Congress on Alternatives and Animal Use in the Life Sciences, Seattle, 2017, http://www.altex.ch/resources/WC10_entire_issue1.pdf.
D. Pamies, T. Hartung, Chem. Res. Toxicol. 2017, 30, 43.
a) P. Nymark, L. Rieswijk, F. Ehrhart, N. Jeliazkova, G. Tsiliki, H. Sarimveis, C. T. Evelo, V. Hongisto, P. Kohonen, E. Willighagen, R. C. Grafström, Toxicol. Sci. 2018, 162, 264;
b) R. Corvi, M. Vilardell, J. Aubrecht, A. Piersma, in Validation of Alternative Methods for Toxicity Testing (Eds: C. Eskes, M. Whelan), Springer International Publishing, Cham 2016, p. 243;
c) R. Stierum, E. Dinant Kroese, J. Vogels, H. Buist, D. Jennen, E. van Someren, in Handbook for Biomarkers & Precision Medicine (Eds: C. Carini, S. Menon, M. Fidock, A. van Gool), Chapman and Hall/CRC 2019, Ch. 2.3;
d) R. Herwig, H. Gmuender, R. Corvi, K. M. Bloch, A. Brandenburg, J. Castell, L. Ceelen, C. Chesne, T. Y. Doktorova, D. Jennen, P. Jennings, A. Limonciel, E. A. Lock, T. McMorrow, P. Phrakonkham, R. Radford, C. Slattery, R. Stierum, M. Vilardell, T. Wittenberger, R. Yildirimman, M. Ryan, V. Rogiers, J. Kleinjans, Arch. Toxicol. 2016, 90, 2215;
e) A. Williams, S. Halappanavar, Beilstein J. Nanotechnol. 2015, 6, 2438;
f) J. Nikota, A. Williams, C. L. Yauk, H. Wallin, U. Vogel, S. Halappanavar, Part. Fibre Toxicol. 2015, 13, 25.
a) A. Serra, I. Letunic, V. Fortino, R. D. Handy, B. Fadeel, R. Tagliaferri, D. Greco, Sci. Rep. 2019, 9, 179;
b) V. S. Marwah, P. A. S. Kinaret, A. Serra, G. Scala, A. Lauerma, V. Fortino, D. Greco, Bioinformatics 2018, 34, 2136;
c) M. E. Andersen, P. D. McMullen, D. Krewski, Arch. Toxicol. 2015, 89, 809;
d) F. A. Grimm, Y. Iwata, O. Sirenko, G. A. Chappell, F. A. Wright, D. M. Reif, J. Braisted, D. L. Gerhold, J. M. Yeakley, P. Shepard, B. Seligmann, T. Roy, P. J. Boogaard, H. B. Ketelslegers, A. M. Rohde, I. Rusyn, Green Chem. 2016, 18, 4407;
e) L. Smirnova, N. Kleinstreuer, R. Corvi, A. Levchenko, S. Fitzpatrick, T. Hartung, ALTEX 2018, 35, 139.
a) G. Lacroix, W. Koch, D. Ritter, A. C. Gutleb, S. T. Larsen, T. Loret, F. Zanetti, S. Constant, S. Chortarea, B. Rothen-Rutishauser, P. S. Hiemstra, E. Frejafon, P. Hubert, L. Gribaldo, P. Kearns, J.-M. Aublant, S. Diabaté, C. Weiss, A. de Groot, I. Kooter, Appl. In Vitro Toxicol. 2018, 4, 91;
b) V. Stone, H. Johnston, R. P. F. Schins, Crit. Rev. Toxicol. 2009, 39, 613;
c) C. Muoth, L. Aengenheister, M. Kucki, P. Wick, T. Buerki-Thurnherr, Nanomedicine 2016, 11, 941;
d) H. J. Johnston, R. Verdon, S. Gillies, D. M. Brown, T. F. Fernandes, T. B. Henry, A. G. Rossi, L. Tran, C. Tucker, C. R. Tyler, V. Stone, Crit. Rev. Toxicol. 2018, 48, 252;
e) C. Endes, O. Schmid, C. Kinnear, S. Mueller, S. Camarero-Espinosa, D. Vanhecke, E. J. Foster, A. Petri-Fink, B. Rothen-Rutishauser, C. Weder, M. J. D. Clift, Part. Fibre Toxicol. 2014, 11, 40.
a) O. Schmid, F. R. Cassee, Part. Fibre Toxicol. 2017, 14, 52;
b) W. K. Boyes, B. L. M. Thornton, S. R. Al-Abed, C. P. Andersen, D. C. Bouchard, R. M. Burgess, E. A. C. Hubal, K. T. Ho, M. F. Hughes, K. Kitchin, J. R. Reichman, K. R. Rogers, J. A. Ross, P. T. Rygiewicz, K. G. Scheckel, S.-F. Thai, R. G. Zepp, R. M. Zucker, Crit. Rev. Toxicol. 2017, 47, 771;
c) E. D. Kuempel, L. M. Sweeney, J. B. Morris, A. M. Jarabek, J. Occup. Environ. Hyg. 2015, 12, S18;
d) C. Riebeling, A. Luch, M. E. Götz, Nanotoxicology 2016, 10, 343.
a) P. M. Hinderliter, K. R. Minard, G. Orr, W. B. Chrisler, B. D. Thrall, J. G. Pounds, J. G. Teeguarden, Part. Fibre Toxicol. 2010, 7, 36;
b) G. M. DeLoid, J. M. Cohen, G. Pyrgiotakis, S. V. Pirela, A. Pal, J. Liu, J. Srebric, P. Demokritou, Part. Fibre Toxicol. 2015, 12, 32;
c) S. Gangwal, J. S. Brown, A. Wang, K. A. Houck, D. J. Dix, R. J. Kavlock, E. A. C. Hubal, Environ. Health Perspect. 2011, 119, 1539;
d) J. M. Cohen, J. G. Teeguarden, P. Demokritou, Part. Fibre Toxicol. 2014, 11, 20.
M. Li, P. Zou, K. Tyner, S. Lee, AAPS J. 2017, 19, 26.
a) D. M. Reif, M. Sypa, E. F. Lock, F. A. Wright, A. Wilson, T. Cathey, R. R. Judson, I. Rusyn, Bioinformatics 2013, 29, 402;
b) D.-D. Varsou, G. Tsiliki, P. Nymark, P. Kohonen, R. Grafström, H. Sarimveis, J. Chem. Inf. Model. 2018, 58, 543;
c) S. W. Marvel, K. To, F. A. Grimm, F. A. Wright, I. Rusyn, D. M. Reif, BMC Bioinformatics 2018, 19, 80;
d) S. Gangwal, D. M. Reif, S. Mosher, P. P. Egeghy, J. F. Wambaugh, R. S. Judson, E. A. C. Hubal, Sci. Total Environ. 2012, 435-436, 316.
A. Giusti, R. Atluri, R. Tsekovska, A. Gajewicz, M. D. Apostolova, C. L. Battistelli, E. A. J. Bleeker, C. Bossa, J. Bouillard, M. Dusinska, P. Gómez-Fernández, R. C. Grafström, M. Gromelski, Y. Handzhiyski, N. R. Jacobsen, P. Jantunen, K. A. Jensen, A. Mech, J. M. Navas, P. Nymark, A. G. Oomen, T. Puzyn, K. Rasmussen, C. Riebeling, I. Rodriguez-Llopis, S. Sabella, J. Riego Sintes, B. Suarez-Merino, S. Tanasescu, H. Wallin, A. Haase, NanoImpact 2019, 16, 100182.
M. Leist, A. Ghallab, R. Graepel, R. Marchan, R. Hassan, S. H. Bennekou, A. Limonciel, M. Vinken, S. Schildknecht, T. Waldmann, E. Danen, B. van Ravenzwaay, H. Kamp, I. Gardner, P. Godoy, F. Y. Bois, A. Braeuning, R. Reif, F. Oesch, D. Drasdo, S. Höhme, M. Schwarz, T. Hartung, T. Braunbeck, J. Beltman, H. Vrieling, F. Sanz, A. Forsby, D. Gadaleta, C. Fisher, J. Kelm, D. Fluri, G. Ecker, B. Zdrazil, A. Terron, P. Jennings, B. van der Burg, S. Dooley, A. H. Meijer, E. Willighagen, M. Martens, C. Evelo, E. Mombelli, O. Taboureau, A. Mantovani, B. Hardy, B. Koch, S. Escher, C. van Thriel, C. Cadenas, D. Kroese, B. van de Water, J. G. Hengstler, Arch. Toxicol. 2017, 91, 3477.
a) T. Schultz, G. Dimitrova, S. Dimitrov, O. Mekenyan, Altern. Lab. Anim. 2016, 44, 453;
b) G. Vietti, D. Lison, S. van den Brule, Part. Fibre Toxicol. 2015, 13, 11.
a) M. Martens, T. Verbruggen, P. Nymark, R. Grafström, L. Burgoon, H. Aladjov, F. Torres Andón, C. Evelo, E. Willighagen, Front. Genet. 2018, 9, 661;
b) K. E. Tollefsen, S. Scholz, M. T. Cronin, S. W. Edwards, J. de Knecht, K. Crofton, N. Garcia-Reyero, T. Hartung, A. Worth, G. Patlewicz, Regul. Toxicol. Pharmacol. 2014, 70, 629;
c) A. E. Nel, T. F. Malloy, Science 2017, 355, 1016.
V. Stone, S. Pozzi-Mucelli, L. Tran, K. Aschberger, S. Sabella, U. Vogel, C. Poland, D. Balharry, T. Fernandes, S. Gottardo, S. Hankin, M. G. J. Hartl, N. Hartmann, D. Hristozov, K. Hund-Rinke, H. Johnston, A. Marcomini, O. Panzer, D. Roncato, A. T. Saber, H. Wallin, J. J. Scott-Fordsmand, Part. Fibre Toxicol. 2014, 11, 9.
M. T. T. Oosterwijk, M. L. Feber, E. Burello, Nanotoxicology 2016, 10, 780.
P. Kohonen, R. Ceder, I. Smit, V. Hongisto, G. Myatt, B. Hardy, O. Spjuth, R. Grafström, Basic Clin. Pharmacol. Toxicol. 2014, 115, 50.
a) M. D. Wilkinson, M. Dumontier, I. J. Aalbersberg, G. Appleton, M. Axton, A. Baak, N. Blomberg, J.-W. Boiten, L. B. da Silva Santos, P. E. Bourne, J. Bouwman, A. J. Brookes, T. Clark, M. Crosas, I. Dillo, O. Dumon, S. Edmunds, C. T. Evelo, R. Finkers, A. Gonzalez-Beltran, A. J. G. Gray, P. Groth, C. Goble, J. S. Grethe, J. Heringa, P. A. C. 't Hoen, R. Hooft, T. Kuhn, R. Kok, J. Kok, S. J. Lusher, M. E. Martone, A. Mons, A. L. Packer, B. Persson, P. Rocca-Serra, M. Roos, R. van Schaik, S.-A. Sansone, E. Schultes, T. Sengstag, T. Slater, G. Strawn, M. A. Swertz, M. Thompson, J. van der Lei, E. van Mulligen, J. Velterop, A. Waagmeester, P. Wittenburg, K. Wolstencroft, J. Zhao, B. Mons, Sci. Data 2016, 3, 160018;
b) S. Karcher, E. L. Willighagen, J. Rumble, F. Ehrhart, C. T. Evelo, M. Fritts, S. Gaheen, S. L. Harper, M. D. Hoover, N. Jeliazkova, N. Lewinski, R. L. Marchese Robinson, K. C. Mills, A. P. Mustad, D. G. Thomas, G. Tsiliki, C. Ogilvie Hendren, NanoImpact 2018, 9, 85.
G. M. DeLoid, J. M. Cohen, G. Pyrgiotakis, P. Demokritou, Nat. Protoc. 2017, 12, 355.
E. Berggren, A. White, G. Ouedraogo, A. Paini, A.-N. Richarz, F. Y. Bois, T. Exner, S. Leite, L. A. v. Grunsven, A. Worth, C. Mahony, Comput. Toxicol. 2017, 4, 31.
K. Alberi, M. B. Nardelli, A. Zakutayev, L. Mitas, S. Curtarolo, A. Jain, M. Fornari, N. Marzari, I. Takeuchi, M. L. Green, M. Kanatzidis, M. F. Toney, S. Butenko, B. Meredig, S. Lany, U. Kattner, A. Davydov, E. S. Toberer, V. Stevanovic, A. Walsh, N.-G. Park, A. Aspuru-Guzik, D. P. Tabor, J. Nelson, J. Murphy, A. Setlur, J. Gregoire, H. Li, R. Xiao, A. Ludwig, L. W. Martin, A. M. Rappe, S.-H. Wei, J. Perkins, J. Phys. D: Appl. Phys. 2019, 52, 013001.
R. J. Kavlock, T. Bahadori, T. S. Barton-Maclaren, M. R. Gwinn, M. Rasenberg, R. S. Thomas, Chem. Res. Toxicol. 2018, 31, 287.

Auteurs

Penny Nymark (P)

Karolinska Institutet, Institute of Environmental Medicine, Nobels väg 13, 171 77, Stockholm, Sweden.
Department of Toxicology, Misvik Biology, Karjakatu 35 B, 20520, Turku, Finland.

Martine Bakker (M)

National Institute for Public Health and the Environment, RIVM, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.

Susan Dekkers (S)

National Institute for Public Health and the Environment, RIVM, P.O. Box 1, 3720 BA, Bilthoven, The Netherlands.

Remy Franken (R)

Netherlands Organisation for Applied Scientific Research, TNO, P.O. Box 96800, NL-2509 JE, The Hague, The Netherlands.

Wouter Fransman (W)

Netherlands Organisation for Applied Scientific Research, TNO, P.O. Box 96800, NL-2509 JE, The Hague, The Netherlands.

Amaia García-Bilbao (A)

GAIKER Technology Centre, Parque Tecnológico, Ed. 202, 48170, Zamudio, Bizkaia, Spain.

Dario Greco (D)

Faculty of Medicine and Health Technology, Tampere University, Korkeakoulunkatu 6, 33720, Tampere, Finland.
Institute of Biotechnology, University of Helsinki, P.O. Box 56, FI-00014, Helsinki, Finland.

Mary Gulumian (M)

National Institute for Occupational Health, 25 Hospital St, Constitution Hill, 2000, Johannesburg, South Africa.
Haematology and Molecular Medicine Department, University of the Witwatersrand, 7 York Road, Parktown, 2193, Johannesburg, South Africa.

Niels Hadrup (N)

National Research Center for the Work Environment, Lersø Parkallé 105, 2100, Copenhagen, Denmark.

Sabina Halappanavar (S)

Environmental Health Science and Research Bureau, Health Canada, 50 Colombine Driveway, Ottawa, ON, K1A 0K9, Canada.

Vesa Hongisto (V)

Department of Toxicology, Misvik Biology, Karjakatu 35 B, 20520, Turku, Finland.

Karin Sørig Hougaard (KS)

National Research Center for the Work Environment, Lersø Parkallé 105, 2100, Copenhagen, Denmark.

Keld Alstrup Jensen (KA)

National Research Center for the Work Environment, Lersø Parkallé 105, 2100, Copenhagen, Denmark.

Pekka Kohonen (P)

Karolinska Institutet, Institute of Environmental Medicine, Nobels väg 13, 171 77, Stockholm, Sweden.
Department of Toxicology, Misvik Biology, Karjakatu 35 B, 20520, Turku, Finland.

Antti Joonas Koivisto (AJ)

National Research Center for the Work Environment, Lersø Parkallé 105, 2100, Copenhagen, Denmark.

Miikka Dal Maso (M)

Aerosol Physics Laboratory, Physics Unit, Tampere University, Korkeakoulunkatu 6, 33720, Tampere, Finland.

Thies Oosterwijk (T)

Netherlands Organisation for Applied Scientific Research, TNO, P.O. Box 96800, NL-2509 JE, The Hague, The Netherlands.

Mikko Poikkimäki (M)

Aerosol Physics Laboratory, Physics Unit, Tampere University, Korkeakoulunkatu 6, 33720, Tampere, Finland.

Isabel Rodriguez-Llopis (I)

GAIKER Technology Centre, Parque Tecnológico, Ed. 202, 48170, Zamudio, Bizkaia, Spain.

Rob Stierum (R)

Netherlands Organisation for Applied Scientific Research, TNO, P.O. Box 96800, NL-2509 JE, The Hague, The Netherlands.

Jorid Birkelund Sørli (JB)

National Research Center for the Work Environment, Lersø Parkallé 105, 2100, Copenhagen, Denmark.

Roland Grafström (R)

Karolinska Institutet, Institute of Environmental Medicine, Nobels väg 13, 171 77, Stockholm, Sweden.
Department of Toxicology, Misvik Biology, Karjakatu 35 B, 20520, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH